Religare Enterprises Limited (BOM:532915)
India · Delayed Price · Currency is INR 244.30
-8.40 (-3.32%)
At close: Feb 13, 2026
Religare Enterprises Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Premiums & Annuity Revenue | 69,065 | 63,459 | 53,254 | 39,293 | 25,091 | 17,295 |
Total Interest & Dividend Income | 8,222 | 6,975 | 6,019 | 5,098 | 4,617 | 5,432 |
Gain (Loss) on Sale of Investments | 228.99 | 228.99 | 107.75 | 88.71 | 154.41 | -170.65 |
Other Revenue | 3,072 | 3,151 | 3,317 | 2,304 | 3,767 | 2,484 |
Total Revenue | 80,589 | 73,814 | 62,698 | 46,784 | 33,630 | 25,040 |
Revenue Growth (YoY) | 11.74% | 17.73% | 34.02% | 39.11% | 34.31% | 6.91% |
Policy Acquisition & Underwriting Costs | 14,649 | 14,461 | 11,611 | 5,095 | 1,835 | 888.81 |
Depreciation & Amortization | 508.32 | 600.06 | 717.04 | 561.46 | 534.02 | 588.41 |
Selling, General & Administrative | 1,481 | 1,481 | 1,892 | 4,461 | 3,350 | 2,003 |
Provision for Bad Debts | 980.23 | 980.23 | 3,124 | 2,221 | 275.52 | 64.52 |
Other Operating Expenses | 50,956 | 43,696 | 35,916 | 23,906 | 18,865 | 12,547 |
Total Operating Expenses | 78,475 | 71,036 | 59,749 | 42,561 | 36,521 | 22,789 |
Operating Income | 2,114 | 2,778 | 2,949 | 4,223 | -2,891 | 2,251 |
Interest Expense | -299.58 | -352.37 | -911.05 | -6,265 | -7,380 | -7,199 |
Earnings From Equity Investments | - | - | - | - | -0.97 | -0.84 |
Currency Exchange Gain (Loss) | 8.44 | 8.44 | -2.38 | - | -5.03 | -10.09 |
Other Non Operating Income (Expenses) | 17.04 | 17.04 | 135.44 | 1,733 | -37.54 | -19.44 |
EBT Excluding Unusual Items | 1,840 | 2,451 | 2,171 | -308.61 | -10,314 | -4,978 |
Impairment of Goodwill | -19.95 | -19.95 | - | - | - | - |
Gain (Loss) on Sale of Assets | 2.05 | 2.05 | 2.6 | 0.84 | 3.27 | 3.62 |
Other Unusual Items | - | - | 2,303 | 32,894 | - | - |
Pretax Income | 1,822 | 2,433 | 4,477 | 32,586 | -10,311 | -4,975 |
Income Tax Expense | 533.97 | 599.76 | 1,003 | 900.16 | 5,075 | -196.44 |
Earnings From Continuing Ops. | 1,288 | 1,833 | 3,474 | 31,686 | -15,385 | -4,778 |
Minority Interest in Earnings | -260.03 | -581.31 | -1,145 | -869.31 | -53.52 | -306.44 |
Net Income | 1,028 | 1,252 | 2,329 | 30,817 | -15,439 | -5,085 |
Net Income to Common | 1,028 | 1,252 | 2,329 | 30,817 | -15,439 | -5,085 |
Net Income Growth | -32.05% | -46.25% | -92.44% | - | - | - |
Shares Outstanding (Basic) | 338 | 330 | 327 | 321 | 301 | 259 |
Shares Outstanding (Diluted) | 338 | 330 | 329 | 325 | 301 | 259 |
Shares Change (YoY) | 2.19% | 0.46% | 1.06% | 8.20% | 16.25% | 9.75% |
EPS (Basic) | 3.04 | 3.79 | 7.13 | 96.06 | -51.33 | -19.65 |
EPS (Diluted) | 3.04 | 3.78 | 7.07 | 94.67 | -51.33 | -19.69 |
EPS Growth | -33.46% | -46.49% | -92.53% | - | - | - |
Free Cash Flow | - | 15,470 | 14,782 | 14,656 | 15,564 | 13,544 |
Free Cash Flow Per Share | - | 46.82 | 44.95 | 45.03 | 51.74 | 52.34 |
Operating Margin | 2.62% | 3.76% | 4.70% | 9.03% | -8.60% | 8.99% |
Profit Margin | 1.28% | 1.70% | 3.72% | 65.87% | -45.91% | -20.31% |
Free Cash Flow Margin | - | 20.96% | 23.58% | 31.33% | 46.28% | 54.09% |
EBITDA | 2,276 | 2,947 | 3,127 | 4,403 | -2,767 | 2,368 |
EBITDA Margin | 2.82% | 3.99% | 4.99% | 9.41% | -8.23% | 9.46% |
D&A For EBITDA | 161.94 | 168.89 | 178.15 | 180.29 | 123.77 | 116.58 |
EBIT | 2,114 | 2,778 | 2,949 | 4,223 | -2,891 | 2,251 |
EBIT Margin | 2.62% | 3.76% | 4.70% | 9.03% | -8.60% | 8.99% |
Effective Tax Rate | 29.31% | 24.65% | 22.40% | 2.76% | - | - |
Revenue as Reported | 80,743 | 73,969 | 62,993 | 48,632 | 33,724 | 25,305 |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.